Cite
HARVARD Citation
Qin, Y. et al. (2016). Combination of White Blood Cell Count at Presentation With Molecular Response at 3 Months Better Predicts Deep Molecular Responses to Imatinib in Newly Diagnosed Chronic-Phase Chronic Myeloid Leukemia Patients. Medicine. 95 (2), pp. e2486-. [Online].